We operate a comprehensive clinical trial site network across India’s major metros and key regional hubs. This multi-setting footprint enables precise alignment of protocol requirements with the right investigators, infrastructure, and patient populations.

Our pan-India clinical trial network spans the

• North & NCR (Delhi, Gurugram, Noida, Faridabad, Chandigarh, Ludhiana, Jaipur, Udaipur),
• Central & West (Mumbai, Pune, Ahmedabad, Indore, Bhopal)
• South (Bengaluru, Chennai, Coimbatore, Hyderabad, Mangalore, Trivandrum, Kochi)
• East (Kolkata, Bhubaneswar), and North-East (Guwahati, Silchar)

enabling rapid site activation, balanced regional enrollment, and access to diverse patient populations across academic, corporate, and private healthcare settings.

Our geographic breadth ensures rapid site activation, balanced regional enrollment, and access to diverse patient populations, supporting both city-centric pilots and nationwide study rollouts. With experienced investigators, established ethics committee pathways, and scalable coordination models, our site network is designed to deliver consistent quality, regulatory compliance, and enrollment efficiency across therapeutic areas.

Our trial sites span a comprehensive spectrum of healthcare settings, including government and academic teaching hospitals, large private and corporate hospital chains, and specialist private clinics. This diversified, multi-setting footprint allows us to strategically align each study protocol with the most appropriate investigators, clinical infrastructure, and patient populations, ensuring scientific rigor and operational efficiency from study start-up through close-out.

• Government and academic institutions provide access to high-volume, treatment-naïve patient pools, robust ethics oversight, and experienced investigators engaged in investigator-initiated and academic research.
• Corporate and private hospital networks offer advanced diagnostic capabilities, standardized processes, rapid study initiation, and strong compliance with global GCP standards, making them well-suited for complex interventional trials and time-sensitive programs.
• Specialist clinics contribute deep therapeutic focus, consistent follow-up, and high patient engagement, particularly valuable for niche indications, device studies, and real-world evidence generation.

This integrated site ecosystem enables faster feasibility assessments, optimized enrollment strategies, reduced screen-failure rates, and improved data quality. By matching the right site environment to the scientific and operational needs of each protocol, we help sponsors achieve reliable enrollment, consistent execution, and high-quality evidence generation across diverse therapeutic areas and study designs.